The release of COVID-19 vaccine results after the 2020 election may have not been a “coincidence” — and could have been part of an effort by senior Pfizer executives to “deliberately slow down” the testing, according to bombshell allegations from a Republican-led congressional panel.
The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr. Philip Dormitzer, may have “conspired to withhold public health information to influence” the presidential contest between Donald Trump and Joe Biden.
The London-based drugmaker GSK in an April 16 letter to Judiciary Chairman Jim Jordan (R-Ohio) disclosed that Dormitzer “approached a representative from the GSK human resources team to speak about a potential relocation abroad” in November 2024.
According to the HR rep, the ex-Pfizer vaccine scientist was “visibly upset” in the meeting and asked to be moved to Canada “due to concerns that he could be investigated by the incoming Trump Administration over his role in developing Pfizer’s COVID-19 vaccine.”
When the GSK employee asked what his reasons were for requesting the relocation, Dormitzer apparently responded: “Let’s just say it wasn’t a coincidence, the timing of the vaccine.”
Pfizer used independent experts to review the effectiveness and safety of its vaccines and broadcast the results being shared by its scientists just five days after polls closed for the 2020 election on Nov. 3.
GSK also divulged in the letter that some of its employees heard from the scientist “in late 2020, the three most senior people in Pfizer R&D were involved in a decision to deliberately slow down clinical testing so that it would not be complete prior to the results of the presidential election that year.”
But the drugmaker, in its letter, also denied that Dormitzer was copping to “delaying disclosure of completed results,” characterizing his statements as being part of “a situation of slowing down results before disclosure became necessary.”
The Judiciary panel still fired off a pair of letters to Dormitzer and Pfizer’s chairman and CEO, Dr. Albert Bourla, on Thursday demanding all records — including emails, texts, meeting notes and other documents — showing data from the clinical trials or communications with federal public health agencies. --->READ MORE HERE
A former Pfizer scientist said the timing of the 2020 vaccine results ‘wasn’t a coincidence,’ according to allegations provided by a rival drugmaker
Lawmakers are investigating whether Pfizer waited to share results of the Covid vaccine in 2020 until after that year’s presidential election, based on new allegations that a former Pfizer scientist has said he was part of an effort to “deliberately slow down” the testing, according to a new letter from the House Judiciary Committee.
The House panel is seeking information from Pfizer and from the scientist, Philip Dormitzer, after learning he allegedly told colleagues in 2024 at a subsequent job he was worried he would face an investigation of his role in the vaccine’s release and asked to be relocated to Canada.
Dormitzer has since denied that he or anyone at Pfizer tried to delay the vaccine, and has said that his comments to colleagues at drugmaker GSK, where he took a job in 2021, have been misinterpreted. GSK first reported Dormitzer’s alleged comments to federal prosecutors in New York late last year, leading them to launch a probe into Pfizer’s vaccine timing.
According to GSK’s account to the House panel, Dormitzer told colleagues at the British drugmaker last year that three of the most senior people at Pfizer R&D were “involved in a decision to deliberately slow down clinical testing so that it would not be complete prior to the results of the presidential election that year.”
The GSK employees also recounted that Dormitzer “was clear that this was not a situation of delaying disclosure of completed results but was a situation of slowing down results before disclosure became necessary,” according to the letter.
GSK’s report to the house panel alleges that in asking for the move to Canada, a “visibly upset” Dormitzer told a GSK human resources official that the timing of the release “wasn’t a coincidence.”
A lawyer for Dormitzer, who has since left GSK, didn’t immediately respond to requests for comment. --->READ MORE HERE (or HERE)Follow links below to relevant/related stories and resources:
Increasing differences in older people's COVID-19 protection
Memphis business woman must pay $500k for healthcare and COVID-19 relief fraud
USA TODAY: Coronavirus Updates
WSJ: Coronavirus Live Updates
YAHOO NEWS: Coronavirus Live Updates
NEW YORK POST: Coronavirus The Latest
If you like what you see, please "Like" and/or Follow us on FACEBOOK here, GETTR here, and TWITTER here.
No comments:
Post a Comment